Stocksigma LogoStocksigma Logo

Speciality Medicines H1 FY27 Results: PAT Surges 83% YoY to ₹8.88 Crore

Speciality Medicines reported revenue from operations of ₹86.95 crore for the half-year ended 30th Sep'26, jumping 185% YoY from ₹30.50 crore and 94% QoQ

Speciality Medicines H1 FY27 Results: PAT Surges 83% YoY to ₹8.88 Crore

Speciality Medicines Ltd · Financial Result · 12 Nov 2026, 10:00 pm

Speciality Medicines H1 FY27 Results: PAT Surges 83% YoY to ₹8.88 Crore Speciality Medicines reported revenue from operations of ₹86.95 crore for the half-year ended 30th Sep'26, jumping 185% YoY from ₹30.50 crore and 94% QoQ from ₹44.78 crore in the preceding half-year. Net profit rose 83.18% YoY and 8.58% QoQ to ₹8.88 crore, compared to ₹4.85 crore in H1 FY26. Diluted EPS stood at ₹10.11 versus ₹7.54 YoY. Additionally, the company reported zero deviation in utilizing its ₹29.14 crore IPO proceeds, having deployed ₹17.95 crore by 30th Sep'26.

Original exchange filing (PDF)

More announcements from Speciality Medicines Ltd

All Speciality Medicines Ltd announcements